Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib + Aromatase Inhibitors in HR+/HER2- MBC (LUZERN)
NCT04240106Phase 2Completed
- Sponsor
- MEDSIR
- Start
- Jun 2020
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niraparib in breast cancer, sponsored by MEDSIR. Started Jun 2020; status: completed.
02
Drugs
niraparib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04240106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04240106.